Zucchelli S, Vilotti S, Calligaris R, Lavina ZS, Biagioli M, Foti R, De Maso L, Pinto M, Gorza M, Speretta E, Casseler C, Tell G, Del Sal G, Gustincich S

Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations.

Cell Death Differ 2009; 428-38. doi: 10.1038/cdd.2008.169

Smith E, Dejsuphong D, Balestrini A, Hampel M, Lenz C, Takeda S, Vindigni A, Costanzo V

An ATM- and ATR-dependent checkpoint inactivates spindle assembly by targeting CEP63.

Nat Cell Biol 2009; 278-85. doi: 10.1038/ncb1835

Farinazzo A, Restuccia U, Bachi A, Guerrier L, Fortis F, Boschetti E, Fasoli E, Citterio A, Righetti PG

Chicken egg yolk cytoplasmic proteome, mined via combinatorial peptide ligand libraries.

J Chromatogr A 2009; 1241-52. doi: 10.1016/j.chroma.2008.11.051

Evan GI, d'Adda di Fagagna F

Cellular senescence: hot or what?

Curr Opin Genet Dev 2009; 25-31. doi: 10.1016/j.gde.2008.11.009

Lymboussaki A, Gemelli C, Testa A, Facchini G, Ferrari F, Mavilio F, Grande A

PPARdelta is a ligand-dependent negative regulator of vitamin D3-induced monocyte differentiation.

Carcinogenesis 2009; 230-7. doi: 10.1093/carcin/bgn272

Coppe A, Ferrari F, Bisognin A, Danieli GA, Ferrari S, Bicciato S, Bortoluzzi S

Motif discovery in promoters of genes co-localized and co-expressed during myeloid cells differentiation.

Nucleic Acids Res 2009; 533-49. doi: 10.1093/nar/gkn948

Rustighi A, Tiberi L, Soldano A, Napoli M, Nuciforo P, Rosato A, Kaplan F, Capobianco A, Pece S, Di Fiore PP, Del Sal G

The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.

Nat Cell Biol 2009; 133-42. doi: 10.1038/ncb1822

Gianni' M, Boldetti A, Guarnaccia V, Rambaldi A, Parrella E, Raska I, Rochette-Egly C, Del Sal G, Rustighi A, Terao M, Garattini E

Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.

Cancer Res 2009; 1016-26. doi: 10.1158/0008-5472.CAN-08-2603

Simonetta M, Manzoni R, Mosca R, Mapelli M, Massimiliano L, Vink M, Novak B, Musacchio A, Ciliberto A

The influence of catalysis on mad2 activation dynamics.

PLoS Biol 2009; e10. doi: 10.1371/journal.pbio.1000010

Generali D, Buffa FM, Berruti A, Brizzi MP, Campo L, Bonardi S, Bersiga A, Allevi G, Milani M, Aguggini S, Papotti M, Dogliotti L, Bottini A, Harris AL, Fox SB

Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.

J Clin Oncol 2009; 227-34. doi: 10.1200/JCO.2007.13.7083

Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, Martello G, Stinchfield MJ, Soligo S, Morsut L, Inui M, Moro S, Modena N, Argenton F, Newfeld SJ, Piccolo S

FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.

Cell 2009; 123-35. doi: 10.1016/j.cell.2008.10.051

Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, Frattini M, Molinari F, Knowles M, Cerrato A, Rodolfo M, Scarpa A, Felicioni L, Buttitta F, Malatesta S, Marchetti A, Bardelli A

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.

Hum Mutat 2009; 7-11. doi: 10.1002/humu.20937

Margarit I, Rinaudo CD, Galeotti CL, Maione D, Ghezzo C, Buttazzoni E, Rosini R, Runci Y, Mora M, Buccato S, Pagani M, Tresoldi E, Berardi A, Creti R, Baker CJ, Telford JL, Grandi G

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm.

J Infect Dis 2009; 108-15. doi: 10.1086/595564

Tripodo C, Di Bernardo A, Ternullo MP, Guarnotta C, Porcasi R, Ingrao S, Gianelli U, Boveri E, Iannitto E, Franco G, Florena AM

CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.

Haematologica 2009; 127-30. doi: 10.3324/haematol.13598

Bertuzzi F, Cainarca S, Marzorati S, Bachi A, Antonioli B, Nano R, Verzaro R, Ricordi C

Collagenase isoforms for pancreas digestion.

Cell Transplant 2009; 203-6. doi: 10.3727/096368909788341270

Santoriello C, Deflorian G, Pezzimenti F, Kawakami K, Lanfrancone L, d'Adda di Fagagna F, Mione M

Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells.

Dis Model Mech 2009; 56-67. doi: 10.1242/dmm.001016

Cosentino Lagomarsino M, Sellerio AL, Heijning PD, Bassetti B

Universal features in the genome-level evolution of protein domains.

Genome Biol 2009; R12. doi: 10.1186/gb-2009-10-1-r12

Bermejo R, Katou YM, Shirahige K, Foiani M

ChIP-on-chip analysis of DNA topoisomerases.

Methods Mol Biol 2009; 103-18. doi: 10.1007/978-1-60761-340-4_9

Secchiero P, Sblattero D, Chiaruttini C, Melloni E, Macor P, Zorzet S, Tripodo C, Tedesco F, Marzari R, Zauli G

Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity.

Int J Immunopathol Pharmacol 2009; 73-83. doi: 10.1177/039463200902200109

Di Nicolantonio F, Arena S, Gallicchio M, Zecchin D, Martini M, Flonta SE, Stella GM, Lamba S, Cancelliere C, Russo M, Geuna M, Appendino G, Fantozzi R, Medico E, Bardelli A

Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses.

Proc Natl Acad Sci U S A 2008; 20864-9. doi: 10.1073/pnas.0808757105

Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

J Clin Oncol 2008; 5705-12. doi: 10.1200/JCO.2008.18.0786

Starmans MH, Krishnapuram B, Steck H, Horlings H, Nuyten DS, van de Vijver MJ, Seigneuric R, Buffa FM, Harris AL, Wouters BG, Lambin P

Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types.

Br J Cancer 2008; 1884-90. doi: 10.1038/sj.bjc.6604746

Iannitto E, Ferreri AJ, Minardi V, Tripodo C, Kreipe HH

Angioimmunoblastic T-cell lymphoma.

Crit Rev Oncol Hematol 2008; 264-71. doi: 10.1016/j.critrevonc.2008.06.012

Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, Viola A, Odom S, Rivera J, Colombo MP, Pucillo CE

CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

Immunity 2008; 771-81. doi: 10.1016/j.immuni.2008.08.018

Gee HE, Camps C, Buffa FM, Colella S, Sheldon H, Gleadle JM, Ragoussis J, Harris AL

MicroRNA-10b and breast cancer metastasis.

Nature 2008; E8-9; author reply E9. doi: 10.1038/nature07362

Hao Z, Duncan GS, Seagal J, Su YW, Hong C, Haight J, Chen NJ, Elia A, Wakeham A, Li WY, Liepa J, Wood GA, Casola S, Rajewsky K, Mak TW

Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis.

Immunity 2008; 615-27. doi: 10.1016/j.immuni.2008.07.016

Gemelli C, Orlandi C, Zanocco Marani T, Martello A, Vignudelli T, Ferrari F, Montanari M, Parenti S, Testa A, Grande A, Ferrari S

The vitamin D3/Hox-A10 pathway supports MafB function during the monocyte differentiation of human CD34+ hemopoietic progenitors.

J Immunol 2008; 5660-72. doi: 10.4049/jimmunol.181.8.5660

Bleeker FE, Felicioni L, Buttitta F, Lamba S, Cardone L, Rodolfo M, Scarpa A, Leenstra S, Frattini M, Barbareschi M, Grammastro MD, Sciarrotta MG, Zanon C, Marchetti A, Bardelli A

AKT1(E17K) in human solid tumours.

Oncogene 2008; 5648-50. doi: 10.1038/onc.2008.170

Curnis F, Sacchi A, Gasparri A, Longhi R, Bachi A, Doglioni C, Bordignon C, Traversari C, Rizzardi GP, Corti A

Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif.

Cancer Res 2008; 7073-82. doi: 10.1158/0008-5472.CAN-08-1272

Rambaldi D, Giorgi FM, Capuani F, Ciliberto A, Ciccarelli FD

Low duplicability and network fragility of cancer genes.

Trends Genet 2008; 427-30. doi: 10.1016/j.tig.2008.06.003

Guida E, Bisso A, Fenollar-Ferrer C, Napoli M, Anselmi C, Girardini JE, Carloni P, Del Sal G

Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells.

Cancer Res 2008; 6550-8. doi: 10.1158/0008-5472.CAN-08-0137

Mauri F, McNamee LM, Lunardi A, Chiacchiera F, Del Sal G, Brodsky MH, Collavin L

Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions.

J Biol Chem 2008; 20848-56. doi: 10.1074/jbc.M710186200

%PLACEHOLDER%